Medication info
Risedron Plus Tablet

Risedron Plus Tablet

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mg / 1 tabletCholecalciferol Concentrate Powder›56mg / 1 tablet
Manufacturer / importer
HanGiang HuTex Pharmaceuticals Co., Ltd.
Appearance
Light orange oval film-coated tablet
Packaging
4 tablets/PTP
Approval status
Active

MFDS item code 201604699 · Approved 2016.07.29 · Insurance code 649103150

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
Adults: Administer 1 tablet orally once weekly Older adults: No dose adjustment is necessary because the bioavailability and pharmacokinetics of this medicine in older adults (60 years and older) are similar to those in younger people. Patients with renal impairment: No dose adjustment is necessary for patients with a creatinine clearance of 30ml/min or greater. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30ml/min. Food interferes with the absorption of this medicine, so take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To help the medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it while sitting or standing upright with plenty of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce the absorption of this medicine. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should also not lie down for at least 30 minutes after taking it. Patients with inadequate calcium and vitamin D intake from food should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic illnesses) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements; measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Taking this medicine once weekly provides one week’s supply of vitamin D at 800 IU daily. If a patient forgets to take a dose on the scheduled day, take it on the day they remember. Take the next dose again on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
The safety and efficacy in children and adolescents who are still growing have not been established.

Ingredients

Manufacturer
HanGiang HuTex Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

  • Osteoporosis
View approved original text

Used for the treatment and prevention of osteoporosis in postmenopausal women, and for the treatment of osteoporosis in men.

How to take

Adult dose

Adults: Administer 1 tablet orally once weekly Older adults: No dose adjustment is necessary because the bioavailability and pharmacokinetics of this medicine in older adults (60 years and older) are similar to those in younger people. Patients with renal impairment: No dose adjustment is necessary for patients with a creatinine clearance of 30ml/min or greater. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30ml/min. Food interferes with the absorption of this medicine, so take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To help the medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it while sitting or standing upright with plenty of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce the absorption of this medicine. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should also not lie down for at least 30 minutes after taking it. Patients with inadequate calcium and vitamin D intake from food should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic illnesses) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements; measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Taking this medicine once weekly provides one week’s supply of vitamin D at 800 IU daily. If a patient forgets to take a dose on the scheduled day, take it on the day they remember. Take the next dose again on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

The safety and efficacy in children and adolescents who are still growing have not been established.

Precautions

This medication can irritate the gastrointestinal mucosa, increasing the risk of issues such as esophagitis or esophageal ulcers. If you experience difficulty swallowing, chest pain, or heartburn while taking this medication, you should immediately stop taking it and consult your doctor. This medication must be taken with a sufficient amount of water, and you should remain upright for at least 30 minutes after taking it. If you do not follow these guidelines, you may exacerbate esophageal irritation. Individuals with esophageal issues or upper gastrointestinal diseases such as gastritis, duodenitis, or ulcers should take special precautions when using this medication. Patients with certain diseases or significantly impaired kidney function, as well as those with genetic issues such as lactose intolerance, should not use this medication. It is advisable to avoid taking this medication with foods or medications that contain calcium, magnesium, or iron, as these components may interfere with its absorption. During the treatment, it is crucial to ensure adequate intake of calcium and vitamin D, especially for patients who use steroid medications for long periods. Do not chew or suck on the tablet, and it is recommended not to take it right before bed or upon waking up. Adhering to the prescribed method can help prevent esophageal damage. While taking this medication, there is a rare risk of jaw necrosis or significant pain in bones, joints, or muscles; inform healthcare professionals if such symptoms occur. Women who are pregnant or breastfeeding should consult their physician before taking this medication, as it may affect the fetus or newborn. The safety and efficacy of this medication in children have not been established, hence it is advisable not to use it in that population. In case of overdose, the serum calcium level may drop, leading to symptoms; thus, you should promptly visit a medical institution for possible calcium supplementation treatment. Finally, this medication should be stored out of reach of children, and it is safer not to transfer it to another container.

Side effects

  • esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • perforation
  • bleeding
  • gastric ulcer
  • duodenitis
  • glossitis
  • decreased blood calcium
Show 92 more
  • decreased blood phosphate
  • petechiae
  • anemia
  • bone pain
  • joint pain
  • muscle pain
  • leg cramps
  • bursitis
  • tendonitis
  • depression
  • dizziness
  • insomnia
  • anxiety
  • neuralgia
  • vertigo
  • increased tension
  • sensory abnormalities
  • pharyngitis
  • rhinitis
  • dyspnea
  • pneumonia
  • rash
  • itching
  • skin cancer
  • cataract
  • conjunctivitis
  • otitis media
  • urinary tract infection
  • cystitis
  • injury from accident
  • epidemic cold syndrome
  • headache
  • overdose
  • allergic reaction
  • syncope
  • vasodilation
  • constipation
  • dyspepsia
  • nausea
  • diarrhea
  • gastroenteritis
  • colitis
  • vomiting
  • dry mouth
  • peripheral edema
  • traumatic fracture
  • myalgia
  • arthritis
  • headache
  • dizziness
  • bronchitis
  • sinusitis
  • increased cough
  • fever
  • falling
  • hypercholesterolemia
  • uveitis
  • iritis
  • osteonecrosis of the jaw
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blister
  • loss of appetite
  • muscle pain
  • abdominal pain
  • weakness
  • heartburn
  • epigastric pain
  • chest discomfort
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • fatty liver
  • increased serum alkaline phosphatase
  • facial edema
  • hair loss
  • abnormal olfaction
  • hypocalcemia
  • hypercalcemia
  • hypercalciuria
  • loss of appetite
  • nausea
  • vomiting
  • polyuria
  • weakness
  • somnolence

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication for a longer duration.

Appearance and packaging

Appearance

Light orange oval film-coated tablet

Package unit

4 tablets/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.